OC
BHVN icon

Oppenheimer & Co’s Biohaven BHVN Stock Holding History

Oppenheimer & Co’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Sell
17,679
-1,956
-10% -$21.1K ﹤0.01% 1534
2026
Q1 		$166K Sell
19,635
-1,114
-5% -$12.2K ﹤0.01% 1600
2025
Q4 		$234K Sell
20,749
-10,695
-34% -$132K ﹤0.01% 1371
2025
Q3 		$472K Buy
+31,444
New +$458K 0.01% 1194

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oppenheimer & Co's BHVN Position: Q2 2026 in Review

Oppenheimer & Co reduced its Biohaven (BHVN) stake by 10% in Q2 2026, selling an estimated $21.1K and leaving 17,679 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

Oppenheimer & Co first reported a position in BHVN in Q3 2025 and has held it in 4 quarters since. The position peaked at $472K in Q3 2025. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Oppenheimer & Co held 17,679 shares of Biohaven worth $263K as of Q2 2026.
  • Oppenheimer & Co sold 1,956 Biohaven shares in Q2 2026, an estimated $21.1K.
  • Biohaven made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1534 holding.
  • Oppenheimer & Co first reported a position in Biohaven in Q3 2025 and has held it in 4 quarters since.
  • Oppenheimer & Co's Biohaven position peaked at $472K in Q3 2025.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.